Hikma Pharmaceuticals (HIK) RNS Announcements

Add to Alert list
Date Time Source Announcement
10 Apr 2018 02:34 PM
RNS
Director/PDMR Shareholding
03 Apr 2018 11:19 AM
RNS
Total Voting Rights
29 Mar 2018 09:00 AM
RNS
Hikma launch-Palonosetron Hydrochloride Injection
20 Mar 2018 09:00 AM
RNS
Hikma has launched Ritonavir Tablets USP
19 Mar 2018 03:50 PM
RNS
Director/PDMR Shareholding
14 Mar 2018 07:00 AM
RNS
Final Results
12 Mar 2018 07:00 AM
RNS
Update status on ANDA for generic Advair Diskus®
09 Mar 2018 09:21 AM
RNS
Block Listing Application
27 Feb 2018 12:23 PM
RNS
Notice of Results
20 Feb 2018 07:00 AM
RNS
Sigurdur Olafsson appointed CEO of Hikma
13 Feb 2018 04:43 PM
RNS
Holding(s) in Company
08 Feb 2018 12:41 PM
RNS
Director/PDMR Shareholding
08 Feb 2018 12:39 PM
RNS
Director/PDMR Shareholding
08 Feb 2018 12:37 PM
RNS
Director/PDMR Shareholding
26 Jan 2018 04:56 PM
RNS
Holding(s) in Company
17 Jan 2018 05:22 PM
RNS
Holding(s) in Company
15 Jan 2018 08:00 AM
RNS
Hikma Appoints Dr. Surendera Tyagi
04 Jan 2018 11:19 AM
RNS
Total Voting Rights
19 Dec 2017 09:00 AM
RNS
Hikma reaches licensing agreement with Celltrion
13 Dec 2017 09:00 AM
RNS
Hikma- Dihydroergotamine Mesylate Injection, USP
12 Dec 2017 09:59 AM
RNS
Holding(s) in Company
11 Dec 2017 09:33 AM
RNS
Holding(s) in Company
01 Dec 2017 09:28 AM
RNS
Total Voting Rights
30 Nov 2017 05:47 PM
RNS
Hikma Ventures- $20.5m Series C round for Prognos
28 Nov 2017 10:24 AM
RNS
Announcement
27 Nov 2017 01:38 PM
RNS
Hikma Ventures invests in Biolinq
22 Nov 2017 09:32 AM
RNS
Holding(s) in Company
20 Nov 2017 09:32 AM
RNS
Holding(s) in Company
14 Nov 2017 08:47 AM
RNS
Holding(s) in Company
14 Nov 2017 07:00 AM
RNS
Hikma Acquires Products from Boehringer Ingelheim
09 Nov 2017 07:00 AM
RNS
Trading Statement
08 Nov 2017 04:45 PM
RNS
Holding(s) in Company
03 Nov 2017 09:00 AM
RNS
Hikma launches Flucytosine Capsules USP in US
02 Nov 2017 02:51 PM
RNS
Holding(s) in Company
01 Nov 2017 11:43 AM
RNS
Total Voting Rights
30 Oct 2017 09:26 AM
RNS
Hikma launches Pantoprazole Sodium for Injection
05 Oct 2017 09:49 AM
RNS
Block listing Interim Review
02 Oct 2017 03:36 PM
RNS
Total Voting Rights
28 Sep 2017 03:29 PM
RNS
Holding(s) in Company
25 Sep 2017 11:27 AM
RNS
Holding(s) in Company
14 Sep 2017 03:52 PM
RNS
Holding(s) in Company
25 Aug 2017 08:41 AM
RNS
Holding(s) in Company
17 Aug 2017 07:00 AM
RNS
Hikma announces licensing agreement with Takeda
17 Aug 2017 07:00 AM
RNS
Half-year Report
10 Aug 2017 10:05 AM
RNS
Director/PDMR Shareholding
10 Aug 2017 10:02 AM
RNS
Director/PDMR Shareholding
09 Aug 2017 09:54 AM
RNS
Director/PDMR Shareholding
04 Aug 2017 09:56 AM
RNS
Holding(s) in Company
03 Aug 2017 02:22 PM
RNS
Notice of Results
24 Jul 2017 10:53 AM
RNS
Holding(s) in Company

Hikma Pharmaceuticals is a British multinational pharmaceutical company, founded in 1978, that develops, manufactures, and markets a wide range of generic, branded, and in-licensed pharmaceutical products, with a focus on making high-quality medicines accessible.

Hikma share price launched at 281p in 2005.

 

UK 100

Latest directors dealings